Mangoceuticals, Inc. Common Stock (MGRX) is a Healthcare · Health Information Services company listed on NASDAQ. Price $0.47 (+4.67%), Market cap $0.01B, 52-week low–high $0.16 ~ $2.74.
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth c
Financial statements, price targets, institutional (13F) holdings and related news for Mangoceuticals, Inc. Common Stock are updated in real time on BlackAll Trade.
Mangoceuticals, Inc. Common Stock trades at $0.47 (+4.67%). Real-time quotes and charts are available on BlackAll Trade.
Mangoceuticals, Inc. Common Stock has a market cap of about $0.01B.
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile d